Ching-jang Huang Selected Research

6- (2- (1- (1- (3- ethyl- 3- hydroxypentyloxy)ethyl)- 7- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)spiro(2.5)octane- 4,8- diol

1/2013

Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-jang Huang Research Topics

Disease

2	Hepatocellular Carcinoma (Hepatoma) 11/2006 - 11/2003
1	Chronic Renal Insufficiency 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Hypercalcemia (Milk Alkali Syndrome) 01/2013
1	Secondary Hyperparathyroidism 01/2013
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Chronic Disease (Chronic Diseases) 01/2008
1	Body Weight (Weight, Body) 02/2007
1	Obesity 02/2007

Drug/Important Bio-Agent (IBA)

2	PPAR alphaIBA 02/2007 - 11/2006
2	Acyl-CoA OxidaseIBA 11/2006 - 11/2003
1	6- (2- (1- (1- (3- ethyl- 3- hydroxypentyloxy)ethyl)- 7- methyldihydro- 1H- inden- 4(2H,5H,6H,7H,7alphaH)- ylidene)ethylidene)spiro(2.5)octane- 4,8- diolIBA 01/2013
1	CalciumIBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2013
1	NexusIBA 01/2008
1	Safflower Oil FDA Link 02/2007
1	LeptinIBA 02/2007
1	Oleic Acid (Oleate)IBA 02/2007
1	Messenger RNA (mRNA)IBA 02/2007
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2003

Therapy/Procedure

1	bitter melon extract 11/2003